---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278413910.md"
description: "United Therapeutics shares are trading higher after the company announced a new stock repurchase program of up to $2 billion over the next year."
datetime: "2026-03-09T14:23:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278413910.md)
  - [en](https://longbridge.com/en/news/278413910.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278413910.md)
---

# 

United Therapeutics shares are trading higher after the company announced a new stock repurchase program of up to $2 billion over the next year.

### Related Stocks

- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)

## Related News & Research

- [How FDA RMAT Status For Bioengineered Liver Device At United Therapeutics (UTHR) Has Changed Its Investment Story](https://longbridge.com/en/news/282975066.md)
- [United Therapeutics Director Sold Shares Worth Over $1.0M](https://longbridge.com/en/news/280686000.md)
- [United Therapeutics Corporation Files Initial Statement of Beneficial Ownership for Director Kevin Tracey](https://longbridge.com/en/news/273557357.md)
- [These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings](https://longbridge.com/en/news/277085456.md)
- [Panagora Asset Management Inc. Purchases 65,828 Shares of United Therapeutics Corporation $UTHR](https://longbridge.com/en/news/268428453.md)